When Carbapenem-Hydrolyzing β-Lactamase KPC Meets Escherichia coli ST131 in France

Emergence of Carbapenem-ResistantEscherichia Coliin Taiwan: Resistance Due to Combined CMY-2 Production and Porin Deficiency

(2014) J.H. Chia et al.   JOURNAL OF CHEMOTHERAPY

Spread of OXA-48-Encoding Plasmid in Turkey and Beyond

(2010) A. Carrer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

First Case of New Delhi Metallo- -Lactamase 1-Producing Escherichia coli Infection in Japan

(2010) S. Chihara et al.   CLINICAL INFECTIOUS DISEASES

Escherichia coli producing KPC-2 carbapenemase: first report in Brazil

(2010) Ana Paula D'Alincourt Carvalho-Assef et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Susceptibility Profiles, Molecular Epidemiology, and Detection of KPC-ProducingEscherichia coliIsolates from the New York City Vicinity

(2010) David Landman et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

(2009) Patrice Nordmann et al.   LANCET INFECTIOUS DISEASES

Emergence of imipenem resistance in clinical Escherichia coli during therapy

(2008) Jesús Oteo et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Emergence of carbapenem-resistant Escherichia coli producing CMY-2-type AmpC  -lactamase in Brazil

(2008) M. Pavez et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern

(2008) Johann DD Pitout et al.   LANCET INFECTIOUS DISEASES